Broad Institute of MIT and Harvard is empowering a revolution in biomedicine to accelerate the pace at which the world conquers disease
Propelling the understanding and treatment of disease
Collaborating deeply
Broad Institute is a mission-driven community that brings together researchers in medicine, biology, chemistry, computation, engineering, and mathematics from across MIT, Harvard, and Harvard-affiliated hospitals, along with collaborators around the world
Reaching globally
Broad Institute is committed to addressing medical challenges across the world, including collaborating with scientists and public health experts to address important needs in developing countries
Empowering scientists
Broad Institute fosters an environment in which scientists can take risks on bold ideas with transformative potential
Building partnerships
Broad Institute works to build and sustain international consortia to speed discovery in areas including psychiatric research, infectious disease, cardiovascular disease, and cancer
Promoting inclusion
Broad Institute believes that progress in biomedical research requires a fully inclusive community across sex, race, ethnicity, sexual orientation, age, and gender identity
INSIDE BROAD
News / 03.5.20
Genetic, geographic, and demographic data from more than 30,000 Americans reveal more genetic diversity within ancestry groups than previously thought.Read more
News / 02.14.20
The recent coronavirus (COVID-19) outbreak presents enormous challenges for global health. To aid the global effort, Broad Institute of MIT and Harvard, the McGovern Institute for Brain Research at MIT, and our partner institutions have committed to freely providing information that may be helpful, including by sharing information that may be able to support the development of potential diagnostics.Read more
News / 03.6.20
How the immune system infiltrates tumors, genetic history of the Mediterranean islands, shaping physician-scientist training, and more.Read more
News / 02.28.20
Patient-partnered initiative will enable anyone in the USA and Canada affected by osteosarcoma to participateRead more
News / 02.11.20
Studying mumps virus genomes in 2016 and 2017 filled in gaps about how the disease was spreading in Massachusetts and elsewhere in the US.Read more
News / 02.20.20
A deep-learning model identifies a powerful new drug that can kill many species of antibiotic-resistant bacteria.Read more
News / 02.10.20
New base editors make fewer off-target edits and can access more locations on the genome than earlier versions.Read more
News / 02.10.20
Largest study yet of angiosarcoma reveals new mutations and suggests therapeutic possibilities for some subtypesRead more
News / 02.10.20
After living with angiosarcoma for decades, Jim Chapdelaine found support in an online community of patients and contributed to research that’s now shedding light on the roots of his own illnessRead more
News / 02.5.20
Pan-Cancer Project brings researchers closer to identifying all major cancer-causing genetic mutations.Read more
News / 01.27.20
Using a single-needle biopsy and new technology for tumor diagnosis, researchers provide a more detailed window into cancer biology, tumor type, and mechanisms of therapy response and resistanceRead more
Spotlight / 03.5.20
Watch Puneet Batra, Danielle Ciofani, and Stacey Gabriel's talk on how sequencing and data sciences are bringing new insights to disease.Read more
Blog / 02.3.20
Eno-Abasi Augustine-Akpan talks about her career shift and her passion for mentoring young girls of color in science.Read more
Blog / 01.16.20
Aida Badiane and Katie Siddle talk about their work on malaria and other fever-causing pathogens and the changes they’ve seen in public health and research in the West African country.Read more